Progyny, Inc. (PGNY) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $26.68 (-0.85%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 6, 2026 | Brian Tanquilut | Jefferies | $30.00 | +12.4% |
| Mar 2, 2026 | Jailendra Singh | Truist Financial | $28.00 | +4.9% |
| Jan 8, 2026 | Jailendra Singh | Truist Financial | $34.00 | +27.4% |
| Jan 8, 2026 | Scott Schoenhaus | KeyBanc | $32.00 | +19.9% |
| Dec 8, 2025 | Peter Warendorf | Barclays | $29.00 | +8.7% |
| Aug 8, 2025 | Sarah James | Raymond James | $28.00 | +4.9% |
| Jul 17, 2025 | Jailendra Singh | Truist Financial | $27.00 | +1.2% |
| Nov 13, 2024 | Glen Santangelo | Jefferies | $19.00 | -28.8% |
| Nov 13, 2024 | Sarah James | Cantor Fitzgerald | $22.00 | -17.5% |
| Nov 13, 2024 | Jailendra Singh | Truist Financial | $19.00 | -28.8% |
| Sep 20, 2024 | Richard Close | Canaccord Genuity | $18.00 | -32.5% |
| Sep 20, 2024 | Michael Cherny | Bank of America Securities | $22.00 | -17.5% |
| Sep 19, 2024 | Glen Santangelo | Jefferies | $24.00 | -10.0% |
| Sep 19, 2024 | Jailendra Singh | Truist Financial | $33.00 | +23.7% |
| Aug 7, 2024 | Richard Close | Canaccord Genuity | $24.00 | -10.0% |
| Jul 16, 2024 | Constantine Davides | JMP Securities | $36.00 | +34.9% |
| May 17, 2024 | Jailendra Singh | Truist Financial | $37.00 | +38.7% |
| May 10, 2024 | David Larsen | BTIG | $41.00 | +53.7% |
Top Analysts Covering PGNY
PGNY vs Sector & Market
| Metric | PGNY | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.08 | 2.24 | 2.40 |
| Analyst Count | 12 | 8 | 19 |
| Target Upside | +13.5% | +11475.0% | +17.1% |
| P/E Ratio | 34.65 | 3.88 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.37B | $1.38B | $1.40B | 7 |
| 2027-03-31 | $355M | $367M | $380M | 4 |
| 2027-06-30 | $365M | $378M | $391M | 3 |
| 2027-09-30 | $362M | $374M | $388M | 3 |
| 2027-12-31 | $365M | $378M | $392M | 3 |
| 2028-03-31 | $401M | $415M | $429M | 2 |
| 2028-06-30 | $406M | $420M | $435M | 5 |
| 2028-09-30 | $388M | $402M | $416M | 4 |
| 2028-12-31 | $370M | $384M | $397M | 4 |
| 2029-12-31 | $1.66B | $1.69B | $1.72B | 2 |
| 2030-12-31 | $1.65B | $1.68B | $1.72B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.16 | $1.17 | $1.19 | 7 |
| 2027-03-31 | $0.29 | $0.30 | $0.32 | 1 |
| 2027-06-30 | $0.32 | $0.34 | $0.36 | 1 |
| 2027-09-30 | $0.33 | $0.34 | $0.36 | 1 |
| 2027-12-31 | $0.30 | $0.31 | $0.32 | 1 |
| 2028-03-31 | $0.00 | $0.00 | $0.00 | 2 |
| 2028-06-30 | $0.00 | $0.00 | $0.00 | 2 |
| 2028-09-30 | $0.00 | $0.00 | $0.00 | 2 |
| 2028-12-31 | $0.00 | $0.00 | $0.00 | 2 |
| 2029-12-31 | $1.80 | $1.85 | $1.90 | 1 |
| 2030-12-31 | $1.60 | $1.64 | $1.68 | 1 |
Frequently Asked Questions
What is the analyst consensus for PGNY?
The consensus among 12 analysts covering Progyny, Inc. (PGNY) is Buy with an average price target of $30.80.
What is the highest price target for PGNY?
The highest price target for PGNY is $41.00, set by David Larsen at BTIG on 2024-05-10.
What is the lowest price target for PGNY?
The lowest price target for PGNY is $18.00, set by Richard Close at Canaccord Genuity on 2024-09-20.
How many analysts cover PGNY?
12 analysts have issued ratings for Progyny, Inc. in the past 12 months.
Is PGNY a buy or sell right now?
Based on 12 analyst ratings, PGNY has a consensus rating of Buy (2.08/5) with a +13.5% upside to the consensus target of $30.80.
What are the earnings estimates for PGNY?
Analysts estimate PGNY will report EPS of $1.17 for the period ending 2026-12-31, with revenue estimated at $1.38B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.